Kush Gupta
Overview
Explore the profile of Kush Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jadhav A, Menon A, Gupta K, Singh N
J Drug Target
. 2025 Jan;
:1-10.
PMID: 39883064
Endoplasmic Reticulum (ER) stress is intricately involved in cancer development, progression and response to chemotherapy. ER stress related genes might play an important role in predicting the prognosis in lung...
2.
Gupta K, Roy A, Attwood K, Nipp R, Mukherjee S
Healthcare (Basel)
. 2024 Aug;
12(15).
PMID: 39120199
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer care, with increasing data demonstrating improved survival outcomes using ICIs among patients with advanced gastroesophageal cancer (GEC). ICIs are also associated with...
3.
Gupta A, Roy A, Gupta K, Attwood K, Gandhi A, Edge S, et al.
Breast Cancer Res Treat
. 2024 May;
207(2):383-392.
PMID: 38767787
Background: Experimental evidence in tumor-bearing mouse models shows that exposure to cool, that is, sub-thermoneutral environmental temperature is associated with a higher tumor growth rate and an immunosuppressive tumor immune...
4.
Gupta K, George A, Attwood K, Gupta A, Roy A, Gandhi S, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201502
Background: Cold stress suppresses antitumor response in animal models, leading to tumor growth. Recent studies have also shown a negative correlation between the average annual temperature (AAT) and cancer incidence....
5.
Jaipuria J, Jain A, Gupta S, Sadasukhi N, Kasaraneni P, Singh A, et al.
Indian J Cancer
. 2024 Jan;
60(4):493-500.
PMID: 38195513
Background: Sunitinib remains the first-line treatment for favorable risk metastatic clear cell renal cell cancer (mccRCC). It was conventionally given in the 4/2 schedule; however, toxicity necessitated trying the 2/1...
6.
Gupta K, Elfiky A, Patel E
Discov Med
. 2023 Dec;
35(179):928-935.
PMID: 38058057
Neoadjuvant chemotherapy (NAC) has long been considered technically difficult in locally advanced colon cancer (LACC). However, the introduction of oxaliplatin-based regimens led to a growing interest in NAC for patients...
7.
Julka P, Arya D, Gupta K
Case Rep Oncol
. 2023 Oct;
16(1):1020-1027.
PMID: 37900837
With an estimated 1.88 million new cases and 0.92 million deaths in 2020, colorectal cancer accounts for nearly one-tenth of all new cancer and cancer-related deaths worldwide. Nearly half of...
8.
Kling S, Kalwani N, Winget M, Gupta K, Saliba-Gustafsson E, Baratta J, et al.
J Eval Clin Pract
. 2023 Jul;
30(1):107-118.
PMID: 37459156
Objectives: Exercise stress echocardiograms (stress echos) are overused, whereas exercise stress electrocardiograms (stress ECGs) can be an appropriate, lower-cost substitute. In this post hoc, mixed methods evaluation, we assessed an...
9.
Gupta A, Gupta K, Roy A, Attwood K, Gandhi A, Edge S, et al.
Res Sq
. 2023 Apr;
PMID: 37034618
Background: Experimental evidence in tumor-bearing mouse models shows that exposure to cool, that is, sub-thermoneutral environmental temperature is associated with a higher tumor growth rate with an immunosuppressive tumor immune...
10.
Gupta A, Jatwani K, Gupta K, Qiu J, Dy G
JCO Precis Oncol
. 2023 Feb;
7:e2200476.
PMID: 36809053
No abstract available.